Back to today’s briefing

Story perspectives

Mother Sues FDA Over Child's Death from Abortion Pills

9/27/2025

34 5

Summary

Story summary

Rosalie Markezich of Louisiana joins lawsuit against the FDA, alleging coercion led to her child's death from mail-order abortion pills.
The suit challenges the FDA's 2023 Risk Evaluation and Mitigation Strategy (REMS) for mail-order mifepristone.
Louisiana argues REMS raises Medicaid costs and bills for abortion complications at public hospitals. It cites the Comstock Act's mailing ban as raising questions.

1 of 1

Story summary

Rosalie Markezich of Louisiana joins lawsuit against the FDA, alleging coercion led to her child's death from mail-order abortion pills.
The suit challenges the FDA's 2023 Risk Evaluation and Mitigation Strategy (REMS) for mail-order mifepristone.
Louisiana argues REMS raises Medicaid costs and bills for abortion complications at public hospitals. It cites the Comstock Act's mailing ban as raising questions.